BRCA status and platinum sensitivity in advanced ovarian cancer according to Chemotherapy Response Score
To evaluate a relation between Data were retrospectively collected on patients with unresectable disease undergoing three or four cycles of neoadjuvant chemotherapy and interval debulking surgery at the Gynecologic Oncology Unit of the Catholic University of the Sacred Heart from January 2016 to December 2020. All patients were assessed for A total of 172 patients were included in the analysis, 69 (40%) patients were Patients with